ng-nitroarginine methyl ester has been researched along with No-Reflow Phenomenon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abo-Ramadan, U; Keränen, MA; Koli, K; Krebs, R; Lemström, KB; Neuvonen, PJ; Nykänen, AI; Syrjälä, S; Tikkanen, JM; Tuuminen, R | 1 |
| Bonios, MJ; Charitos, E; Diakos, N; Lazaris, N; Malliaras, K; Nanas, JN; Papalois, A; Papazoglou, P; Pierrakos, CN; Pozios, IA; Terrovitis, JV; Tsolakis, EJ; Venetsanakos, J | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and No-Reflow Phenomenon
| Article | Year |
|---|---|
Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection.
Topics: Animals; Endothelial Cells; Endothelin-1; Enzyme Inhibitors; Gap Junctions; Graft Rejection; Heart Transplantation; Heme Oxygenase-1; Hypoxia-Inducible Factor 1, alpha Subunit; Major Histocompatibility Complex; Male; Microvessels; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; No-Reflow Phenomenon; Polyisoprenyl Phosphates; Primary Graft Dysfunction; Rats; Rats, Inbred WF; Reperfusion Injury; rho-Associated Kinases; Simvastatin | 2011 |
Effects of L-NAME on coronary blood flow, infarct size and the extent of the no-reflow phenomenon.
Topics: Animals; Blood Flow Velocity; Coronary Circulation; Enzyme Inhibitors; Myocardial Infarction; NG-Nitroarginine Methyl Ester; No-Reflow Phenomenon; Swine; Treatment Outcome | 2013 |